Brimonidine Tartrate
Code | Size | Price |
---|
TAR-T6422-100mg | 100mg | £103.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T6422-500mg | 500mg | £172.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Brimonidine tartrate is a quinoxaline derivative and adrenergic α-2 receptor agonist (EC50: 0.45 nM) that is used to manage intraocular pressure associated with open-angle glaucoma or ocular hypertension.
CAS:
70359-46-5
Formula:
C15H16BrN5O6
Molecular Weight:
442.226
Pathway:
GPCR/G Protein; Neuroscience
Purity:
0.9983
SMILES:
O[C@H]([C@@H](O)C(O)=O)C(O)=O.Brc1c(NC2=NCCN2)ccc2nccnc12
Target:
Adrenergic Receptor
References
WoldeMussie E, et al. Invest Ophthalmol Vis Sci, 2001, 42(12), 2849-2855.
Lafuente MP, et al. Exp Eye Res, 2002, 74(2), 181-189.
Gao H, et al. Arch Ophthalmol, 2002, 120(6), 797-803.
Ahmed FA, et al. Brain Res, 2001, 913(2), 133-139.
Greenfield DS, et al. J Glaucoma, 1997, 6(4), 250-258.